S 4194·NJ·senate
Revises certain requirements for prescription of Schedule II controlled dangerous substances via telemedicine and telehealth without in-person examination or review.*
In CommitteeFiled May 11, 2026
Sponsor: Joe Vitale (D)
Latest Action
Substituted by A4852 (ACS)
Jun 30, 2026
Track this bill
Get real-time alerts when S 4194 changes status, plus AI-powered summaries and stage predictions.
Sign up free